COVID-19 Traditional Medicine Treatment Market

Traditional Chinese medicine has been playing a critical role in the prevention, treatment and rehabilitation of the COVID-19.Official figures showed that, up to Sunday, 91.6 percent of the patients in Hubei province, the epicenter of the outbreak, and 92.4 percent of the patients nationwide have been treated with TCM."Three formulas and three medicines" have been proven to be effective in curbing the virus, according to the State Administration of Traditional Chinese Medicine.
COVID-19 Traditional Medicine Treatment Market aims to provide a comprehensive presentation of the global market for COVID-19 Traditional Chinese Medicine Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COVID-19 Traditional Chinese Medicine Treatment. COVID-19 Traditional Medicine Treatment Market contains market size and forecasts of COVID-19 Traditional Chinese Medicine Treatment in global, including the following market information:
Global COVID-19 Traditional Chinese Medicine Treatment Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global COVID-19 Traditional Chinese Medicine Treatment Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five COVID-19 Traditional Chinese Medicine Treatment companies in 2022 (%)
The global COVID-19 Traditional Chinese Medicine Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Lianhua Qingwen Capsule Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of COVID-19 Traditional Chinese Medicine Treatment include Shijiazhuang Yiling Pharmaceutical, Tianjin Chase Sun Pharmaceutical, Beijing Juxiechang Pharmaceutical and Beijing Yiling Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the COVID-19 Traditional Chinese Medicine Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global COVID-19 Traditional Chinese Medicine Treatment Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global COVID-19 Traditional Chinese Medicine Treatment Market Segment Percentages, by Type, 2022 (%)
Lianhua Qingwen Capsule
Xuebijing Injection
Jinhua Qinggan Granule
Global COVID-19 Traditional Chinese Medicine Treatment Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global COVID-19 Traditional Chinese Medicine Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital
Special Clinic
Recovery Center
Global COVID-19 Traditional Chinese Medicine Treatment Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global COVID-19 Traditional Chinese Medicine Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies COVID-19 Traditional Chinese Medicine Treatment revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies COVID-19 Traditional Chinese Medicine Treatment revenues share in global market, 2022 (%)
Key companies COVID-19 Traditional Chinese Medicine Treatment sales in global market, 2018-2023 (Estimated), (K Units)
Key companies COVID-19 Traditional Chinese Medicine Treatment sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Shijiazhuang Yiling Pharmaceutical
Tianjin Chase Sun Pharmaceutical
Beijing Juxiechang Pharmaceutical
Beijing Yiling Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of COVID-19 Traditional Chinese Medicine Treatment, market overview.
Chapter 2: Global COVID-19 Traditional Chinese Medicine Treatment market size in revenue and volume.
Chapter 3: Detailed analysis of COVID-19 Traditional Chinese Medicine Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of COVID-19 Traditional Chinese Medicine Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global COVID-19 Traditional Chinese Medicine Treatment capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.